Qube Research & Technologies (QRT)
ERNA icon

Qube Research & Technologies (QRT)’s Eterna Therapeutics ERNA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$8 – 3514
2024
Q2 		– Hold
0
– – – 3626
2024
Q1 		– Hold
0
– – – 4296
2023
Q4 		– Hold
0
– – – 4185
2023
Q3 		– Hold
0
– – – 3932
2022
Q4 		– Sell
-2
Closed -$4K – 2604
2022
Q3 		$4K Sell
2
-1
-33% -$3.45K ﹤0.01% 2411
2022
Q2 		$10K Buy
+3
New +$21.5K ﹤0.01% 2322
2022
Q1 		– Sell
-10
Closed -$304K – 2594
2021
Q4 		$304K Buy
+10
New +$544K ﹤0.01% 1803

Other funds holding ERNA

Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
CPWM
Cypress Point Wealth Management Dallas, Texas $492M AUM 22.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NW
Naviter Wealth Little Rock, Arkansas $801M AUM 22.2% 1-Year Est. Return
SCA
Sippican Capital Advisors Boston, Massachusetts $164M AUM 35.17% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.16B AUM 20.31% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ERNA Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Eterna Therapeutics (ERNA) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

Qube Research & Technologies (QRT) first reported a position in ERNA in Q4 2021 and has held it in 3 quarters since. The position peaked at $304K in Q4 2021. 13 funds tracked by Wall St. Rank hold ERNA as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Eterna Therapeutics worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Eterna Therapeutics share count unchanged in Q3 2024.
  • Eterna Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3514 holding.
  • Qube Research & Technologies (QRT) first reported a position in Eterna Therapeutics in Q4 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Eterna Therapeutics position peaked at $304K in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.